Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Nationwide Italian study finds renal dysfunction in symptomatic #Waldenström macroglobulinemia assoc w/ worse median OS (139 vs 203 mos, p<0.001) and PFS (80 vs 106 mos, p=0.002); chemoimmunotx assoc w/ better median PFS.”
Title: Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study
Authors: Nicolò Danesin, Francesco Autore, Anna Maria Frustaci, Gianmarco Favrin, Emanuele Cencini, Alessandro Noto, Irene Dogliotti, Jacopo Olivieri, Marcello Riva, Isacco Ferrarini, Anna Maria Barbui, Sara Steffanoni, Dario Marino, Benedetta Puccini, Piero Maria Stefani, Rita Rizzi, Michele Merli, Angela Ferrari, Stefano Luminari, Carlo Visco, Livio Trentin, Andrea Visentin, Annarita Conconi, Simone Ferrero, Marzia Varettoni, Alessandra Tedeschi, Luca Laurenti, Francesco Piazza
You can read the Full Article in British Journal of Haematology.
You can find other articles featuring Robert Z. Orlowski on OncoDaily
